Testing effectiveness (Phase 2)Study completedNCT01611480
What this trial is testing
Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head
Who this might be right for
Actinic Keratosis
Moberg Pharma AB